Video

Combined MIGS & Cataract Surgery Case Study with Dr. Paul Singh

Author(s):

SPONSORED BY BAUSCH + LOMB

Dr. Paul Singh manages postoperative inflammation and pain with LOTEMAX® SM following combined MIGS & Cataract surgery. Interested in learning more?

Sponsored by Bausch + Lomb

Paul Singh, MD

Paul Singh, MD

The Eye Centers of Racine & Kenosha

Dr. Paul Singh manages post-operative inflammation and pain with LOTEMAX® SM following combined MIGS & Cataract surgery.

Interested in learning more? Visit www.lotemaxsm.com and www.bausch.com

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
Related Content
Q&A: Continuum of care, the evolution of cornea, cataract, and refractive surgery
April 26th 2025

Q&A: Continuum of care, the evolution of cornea, cataract, and refractive surgery

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

A woman is seen with a red eye and a hand with a blue glove
March 27th 2025

Fine-tuning the treatment of postoperative endophthalmitis

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
December 19th 2023

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

Floppy iris syndrome risk: Study finds women more susceptible, key drugs identified
March 21st 2025

Floppy iris syndrome risk: Study finds women more susceptible, key drugs identified

Iantrek announces positive 2-year results from clinical study of its bio-interventional platform for uveoscleral outflow enhancement
March 21st 2025

Iantrek announces positive 2-year results from clinical study of its bio-interventional platform for uveoscleral outflow enhancement

© 2025 MJH Life Sciences

All rights reserved.